About SIMEI
Revolutionizing weight management through innovative transdermal semaglutide patch technology.
Our Mission
Making weight management accessible, painless, and effective for everyone.
SIMEI Biotech was founded with a single vision: to eliminate the barriers that prevent millions of people from accessing effective weight management treatments. Our proprietary transdermal patch technology delivers semaglutide through the skin, replacing painful injections with a simple weekly patch.
Based in Hanoi, Vietnam, our team of researchers, clinicians, and engineers works at the intersection of pharmaceutical science and wearable technology to create products that are clinically effective, easy to use, and available worldwide.
Our Values
Innovation
Pioneering transdermal drug delivery technology for semaglutide.
Safety
Rigorous clinical testing and quality control at every step.
Global Reach
Serving patients and partners across 50+ countries.
Partnership
Building long-term relationships with distributors and healthcare providers.
50+
Countries Served
100K+
Patches Delivered
98%
Patient Satisfaction